USFDA NDI notification of Antromax Antrodia cinnamomea mycelia
BriefingWire.com, 5/23/2021 - The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn s Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars.
USFDA acknowledged Antrodia cinnamomea as new dietary ingredients
On April 12th, Greenyn Biotechnology Corporation hosted a seminar - The international development of Taiwan s Antrodia cinnamomea and its clinical application, and announced Antromax s acknowledgement without objection by USFDA NDI. It was a great feat for Greenyn, and will certainly boost the morale of the Antrodia industry to devote more resou
USFDA recognized Antrodia cinnamomea mycelia (NDIN No.1170)
USFDA NDI notification of Antromax Antrodia cinnamomea mycelia
TAIPEI, May 20, 2021 - (ACN Newswire) - The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn s Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars.
Dr. Kao Shung-te (middle) of China Medical University Hospital and Dr. Houng Jer-yiing (left) of I-Shou University Medical School presented the study results of the randomized double-blind clinical trial and the bioavailability of Antromax in different dosages forms, respectively.
Press Release – ACN Newswire The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn’s Antromax …The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn’s Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars.
Hmedium: Taiwan s Antrodia cinnamomea Gains World Recognition
Greenyn Biotechnology received USFDA NDI acknowledgement without objection for Antrodia cinnamomea mycelia Antromax
Taipei, Taiwan (Newsfile Corp. - May 12, 2021) - On April 12th, Greenyn Biotechnology Corporation hosted a seminar - The international development of Taiwan s
Antrodia cinnamomea and its clinical application, and announced Antromax s acknowledgement without objection by USFDA NDI. It was a great feat for Greenyn, and will certainly boost the morale of the Antrodia industry to devote more resources in the US market.
A. cinnamomea is an edible fungus that grows on the endangered
Cinnamomum kanehirae tree, which is found only in Taiwan. This indigenous fungus is traditionally used to ameliorate liver disorders, hangovers, fatigue, and enhance immunity. Ruby of Taiwan was given to this miracle fungus.
Taiwan s Antrodia cinnamomea Gains World Recognition streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.